Proceedings · Session S-101 · filed September 30, 2026
Technology Transfer & IPSession paper
Tech Transfer Timelines: CDMO Panel Targets 8 Months Cut to 8 Weeks
CDMO practitioners detail a three-layer transfer package, gap-handling protocols and analytical target profiles; QbDVision projects digital tools can cut 8-month transfers to 8 weeks.
By Rebecca Stone4 min read854 words
Summary
- Lauren Nolan (Kindeva) says receiving sites typically reach independent operating confidence around the 8-month mark, with further gains through repetition.
- Yash Sabharwal (QbDVision) claims organizations using digital transfer frameworks aim to compress transfer execution from roughly 8 months to 8 weeks — a vendor projection without published case data.
- The panel — Symbiosis, Kindeva, QbDVision and Mabion, in a PharmTech discussion published July 27, 2026 — recommends surfacing process-understanding gaps before execution begins and using structured risk assessments to assign characterization work.
Contract manufacturing organizations and their sponsors should plan for roughly eight months before a receiving site can independently run and troubleshoot a transferred process — or adopt digital transfer frameworks that vendors claim can compress that timeline to eight weeks. That contrast framed a roundtable discussion published by Pharmaceutical Technology on July 27, 2026, featuring Katy MacLellan, technical team leader at Symbiosis; Lauren Nolan, senior director of Operations, Sterile Injectables at Kindeva; Yash Sabharwal, CEO and co-founder of QbDVision; and Judyta Suskiewicz, director of business development at Mabion.
For R&D and outsourcing managers, the discussion offered a working taxonomy of what a transfer package must contain, how to handle gaps discovered mid-transfer, and how to qualify analytical methods — three areas where transfers between sponsors and contract organizations commonly fail.
Three layers, only one of them lives in documents
Nolan structures a transfer package in three layers. The first is documentation: batch records, manufacturing instructions, specifications and analytical methods. She described these as non-negotiable baseline requirements, but not the differentiator between successful and failed transfers.
The second layer is process understanding — the reasoning behind the process that documents alone rarely capture. A receiving site needs visibility into critical process parameters, acceptable operating ranges, historical deviations and lessons learned to identify where genuine risk sits. Without it, a site executes instructions it cannot judge.
The third layer, operational knowledge, is where transfers succeed or fail, according to Nolan. Operator techniques, engineering judgment, campaign sequencing, equipment nuances and practical troubleshooting often never appear in standard operating procedures. The goal, she said, is not for a receiving site to execute a batch record but to independently operate, troubleshoot and improve the process with the same confidence as the sending site. In her experience, that comfort level typically develops around the eight-month mark, with further gains coming through repetition — a timeline managers should build into their outsourcing budgets rather than expect contract terms to eliminate.
The digital claim: eight months to eight weeks
Sabharwal challenged the premise that documents are the right vehicle at all. His company's software platform digitizes product requirements, process definitions, ranges, risk and control strategies into a shared digital framework supporting collaboration, replacing the traditional model of passing documents back and forth.
The claim that adopters aim to compress transfer execution from roughly eight months to eight weeks warrants scrutiny: it is a vendor projection, not a measured benchmark, and the discussion did not present case data with sample sizes or named programs. What is concrete is the architectural argument — the same information, structured once in a shared system rather than re-negotiated through document exchanges.
Gaps: assess first, then decide who pays
MacLellan described a case-by-case approach when gaps surface mid-transfer. The receiving site runs a cross-functional impact assessment to determine risk to product quality or facility operations. Depending on the outcome, it may request additional information from the client or further development work before accepting the drug substance.
Nolan pushed a reframing: gaps are better surfaced during tech transfer than during commercial manufacturing. The first diagnostic question is whether a gap reflects missing documentation or missing scientific understanding. If critical process characterization genuinely has not been completed, the receiving site should not absorb the shortfall; both organizations should run a structured risk assessment to define the additional engineering work, characterization or validation needed. She stressed transparency with the sponsor throughout, arguing that hiding uncertainty only creates larger downstream problems — tech transfer should reduce uncertainty, not relocate it.
Suskiewicz echoed the collaborative framing, describing gaps as shared problems to de-risk and optimize together rather than shortcomings to assign blame for. Her operational advice: identify gaps as early as possible, ideally before execution begins at the receiving site, to improve outcomes for the entire transfer.
Analytical methods: define the target before the procedure
Analytical method transfer is a persistent source of delay and failure. Sabharwal drew a structural parallel: analytical procedure definitions and manufacturing process definitions are architecturally similar, so the same digital transfer tools apply to both, including lifecycle management aligned to International Council for Harmonisation guidelines.
That framework calls for defining an analytical target profile first, linking it back to product quality attributes, and only then building a digital procedure best suited to meet that profile — reversing the common sequence of transferring a written method and debugging it after failures at the receiving site. Sabharwal framed the broader goal as proactive rather than reactive: use available information to identify gaps before execution begins, not after an analytical method has already failed.
For R&D managers weighing CDMO partnerships, the panel's combined message is a checklist with budget implications: verify that process understanding and operational knowledge, not just documents, transfer with the product; pre-agree a risk-assessment protocol for gaps that assigns characterization costs rather than defaulting them to the receiving site; and front-load analytical target profiles ahead of method transfer. Part 2 of the discussion is expected to extend the conversation, and the eight-week digital-transfer claim will be worth testing against adopters' measured results as those programs mature.
via cdn.sanity.io (Original)
Filed under
- tech-transfer
- cdmo
- pharmaceutical-manufacturing
- digital-transformation
- analytical-method-transfer
More from Rebecca Stone
Show full bio
Market editor covering marketplaces and e-commerce at Hypothesis Wire.
80 articles
References
- PharmTech Examines What Actually Drives Tech Transfer Success
- PharmTech Panel Returns to Contractor Technology Transfer
- Biologics Fill-Finish Tech Transfer Draws Operational Scrutiny
- Technology Transfer: The Quiet Bottleneck in Pharma Value
- Sterile Injectables to Hit $984B by 2031, Raising Transfer Stakes